Unichem Laboratories zooms on getting tentative approval for Sitagliptin Tablets

12 Jul 2021 Evaluate

Unichem Laboratories is currently trading at Rs. 338.25, up by 10.45 points or 3.19% from its previous closing of Rs. 327.80 on the BSE.

The scrip opened at Rs. 340.00 and has touched a high and low of Rs. 340.80 and Rs. 334.10 respectively. So far 5708 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 374.90 on 21-May-2021 and a 52 week low of Rs. 180.90 on 10-Jul-2020.

Last one week high and low of the scrip stood at Rs. 340.80 and Rs. 319.70 respectively. The current market cap of the company is Rs. 2381.47 crore.

The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 10.44% and 38.62% respectively.

Unichem Laboratories has received tentative approval for ANDA of Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (USFDA) for a generic version of Januvia (sitagliptin) tablets, 25 mg, 50 mg, and 100 mg, of Merck Sharpe and Dohme Corp (Merck).

Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Product will be commercialized from Unichem’s Goa Plant on receipt of full approval.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

724.50 -2.35 (-0.32%)
03-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.10
Dr. Reddys Lab 1352.75
Cipla 1510.25
Lupin 2367.85
Zydus Lifesciences 975.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.